Revolution Medicines RVMDW Income Statement (2019-2026)

NASDAQ RVMDW
$11.80 -0.47 (-3.83%)
As of: Aug 21, 2026 · 2:16 PM EDT
Reported Financials

Revolution Medicines Quarterly Income Statement

Periods 23 quarters
Latest Jun 2026

Revolution Medicines reported net income of -644.37M for the quarter ended Jun 2026. This income statement covers 23 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Dec2024 Jun2025 Jun2026
Shares Outstanding (Entity) (Quarter)Shares Outstanding (Entity.) (Qtr)
214.34M
Revenue & cost
Revenue (Quarter)Revenue (Qtr)
12.09M11.55M10.03M12.66M8.75M10.13M8.70M1.10M9.46M7.58M9.12M3.36M15.33M7.01M3.82M0.74M
Operating items
Research & Development (Quarter)R&D (Qtr)
394.92M
Amortization - Intangibles (Quarter)Amortization - Intangibles (Qtr)
0.30M
Wages, Salaries and Other (Quarter)Wages (Qtr)
78.63M
Selling, General & Administrative (Quarter)SG&A (Qtr)
110.21M
Operating Expenses (Quarter)Opex (Qtr)
505.13M
Operating Income (Quarter)Op. Inc (Qtr)
-505.13M
EBIT (Quarter)EBIT (Qtr)
-505.13M
Non-operating items
Interest & Investment Income (Quarter)Int & Inv Inc (Qtr)
35.58M
Other Non Operating Income (Quarter)Other Non Op Inc. (Qtr)
-0.01M
Non Operating Income (Quarter)Non Op. Inc. (Qtr)
-139.24M
Net income details
EBT (Quarter)EBT (Qtr)
-644.37M
Tax Provisions (Quarter)Taxes (Qtr)
-0.68M-0.06M0.36M-0.30M-0.10M-3.87M4.19M-0.80M
Profit After Tax (Quarter)PAT (Qtr)
-644.37M
Income from Continuing Operations (Quarter)Income (Continuing) (Qtr)
-644.37M
Consolidated Net Income (Quarter)Consol Net Inc. (Qtr)
-644.37M
Income towards Parent Company (Quarter)Parent Net Inc (Qtr)
-644.37M
Preferred Dividend Payments (Quarter)Pref Dividends (Qtr)
4.25M2.22M
Net Income towards Common Stockholders (Quarter)Net Income (Qtr)
-644.37M
Additional items
EPS (Basic) (Quarter)EPS (Basic) (Qtr)
-3.06
EPS (Diluted) (Quarter)EPS (Diluted) (Qtr)
-3.06
Shares Outstanding (Quarter)Shares Outstanding (Qtr)
210.89M
Shares Outstanding (Diluted) (Quarter)Shares Outstanding (Dil.) (Qtr)
210.89M
EBITDA (Quarter)EBITDA (Qtr)
-505.13M
Interest Expenses (Quarter)Int Expense (Qtr)
2,696.55M
Tax Rate (Quarter)Tax Rate (Qtr)
3.340.21-1.070.400.183.44-2.600.41